The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neglected Tropical Disease Treatments Market Research Report 2025
Synopsis
The global Neglected Tropical Disease Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Disease Treatments.
Report Scope
The Neglected Tropical Disease Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Disease Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd.
Abbott
ZeptoMetrix
InBios International, Inc.
Genome Diagnostics Pvt. Ltd
Omega Diagnostics Group PLC
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
Oscar Medicare Pvt Ltd.
Thermo Fisher Scientific, Inc.
Segment by Type
Conventional Method
Molecular/Modern Method
Segment by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Disease Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Neglected Tropical Disease Treatments market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Disease Treatments.
Report Scope
The Neglected Tropical Disease Treatments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Disease Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd.
Abbott
ZeptoMetrix
InBios International, Inc.
Genome Diagnostics Pvt. Ltd
Omega Diagnostics Group PLC
Coris Bioconcept SPRL
DiaSys Diagnostic Systems GmbH
Oscar Medicare Pvt Ltd.
Thermo Fisher Scientific, Inc.
Segment by Type
Conventional Method
Molecular/Modern Method
Segment by Application
Clinical Labs
Hospitals /Clinics
Home Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Disease Treatments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Disease Treatments Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Conventional Method
1.2.3 Molecular/Modern Method
1.3 Market by Application
1.3.1 Global Neglected Tropical Disease Treatments Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Labs
1.3.3 Hospitals /Clinics
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Disease Treatments Market Perspective (2019-2030)
2.2 Neglected Tropical Disease Treatments Growth Trends by Region
2.2.1 Global Neglected Tropical Disease Treatments Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Disease Treatments Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Disease Treatments Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Disease Treatments Market Dynamics
2.3.1 Neglected Tropical Disease Treatments Industry Trends
2.3.2 Neglected Tropical Disease Treatments Market Drivers
2.3.3 Neglected Tropical Disease Treatments Market Challenges
2.3.4 Neglected Tropical Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Disease Treatments Players by Revenue
3.1.1 Global Top Neglected Tropical Disease Treatments Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Disease Treatments Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Disease Treatments Revenue
3.4 Global Neglected Tropical Disease Treatments Market Concentration Ratio
3.4.1 Global Neglected Tropical Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Disease Treatments Revenue in 2023
3.5 Neglected Tropical Disease Treatments Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Disease Treatments Product Solution and Service
3.7 Date of Enter into Neglected Tropical Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Disease Treatments Breakdown Data by Type
4.1 Global Neglected Tropical Disease Treatments Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Disease Treatments Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Disease Treatments Breakdown Data by Application
5.1 Global Neglected Tropical Disease Treatments Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Disease Treatments Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Disease Treatments Market Size (2019-2030)
6.2 North America Neglected Tropical Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Disease Treatments Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Disease Treatments Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Disease Treatments Market Size (2019-2030)
7.2 Europe Neglected Tropical Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Disease Treatments Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Disease Treatments Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Disease Treatments Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Disease Treatments Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Disease Treatments Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Disease Treatments Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Disease Treatments Market Size (2019-2030)
9.2 Latin America Neglected Tropical Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Disease Treatments Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Disease Treatments Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Disease Treatments Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Disease Treatments Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Disease Treatments Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Disease Treatments Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Detail
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Neglected Tropical Disease Treatments Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Neglected Tropical Disease Treatments Introduction
11.2.4 Abbott Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 ZeptoMetrix
11.3.1 ZeptoMetrix Company Detail
11.3.2 ZeptoMetrix Business Overview
11.3.3 ZeptoMetrix Neglected Tropical Disease Treatments Introduction
11.3.4 ZeptoMetrix Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.3.5 ZeptoMetrix Recent Development
11.4 InBios International, Inc.
11.4.1 InBios International, Inc. Company Detail
11.4.2 InBios International, Inc. Business Overview
11.4.3 InBios International, Inc. Neglected Tropical Disease Treatments Introduction
11.4.4 InBios International, Inc. Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.4.5 InBios International, Inc. Recent Development
11.5 Genome Diagnostics Pvt. Ltd
11.5.1 Genome Diagnostics Pvt. Ltd Company Detail
11.5.2 Genome Diagnostics Pvt. Ltd Business Overview
11.5.3 Genome Diagnostics Pvt. Ltd Neglected Tropical Disease Treatments Introduction
11.5.4 Genome Diagnostics Pvt. Ltd Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.5.5 Genome Diagnostics Pvt. Ltd Recent Development
11.6 Omega Diagnostics Group PLC
11.6.1 Omega Diagnostics Group PLC Company Detail
11.6.2 Omega Diagnostics Group PLC Business Overview
11.6.3 Omega Diagnostics Group PLC Neglected Tropical Disease Treatments Introduction
11.6.4 Omega Diagnostics Group PLC Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.6.5 Omega Diagnostics Group PLC Recent Development
11.7 Coris Bioconcept SPRL
11.7.1 Coris Bioconcept SPRL Company Detail
11.7.2 Coris Bioconcept SPRL Business Overview
11.7.3 Coris Bioconcept SPRL Neglected Tropical Disease Treatments Introduction
11.7.4 Coris Bioconcept SPRL Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.7.5 Coris Bioconcept SPRL Recent Development
11.8 DiaSys Diagnostic Systems GmbH
11.8.1 DiaSys Diagnostic Systems GmbH Company Detail
11.8.2 DiaSys Diagnostic Systems GmbH Business Overview
11.8.3 DiaSys Diagnostic Systems GmbH Neglected Tropical Disease Treatments Introduction
11.8.4 DiaSys Diagnostic Systems GmbH Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.8.5 DiaSys Diagnostic Systems GmbH Recent Development
11.9 Oscar Medicare Pvt Ltd.
11.9.1 Oscar Medicare Pvt Ltd. Company Detail
11.9.2 Oscar Medicare Pvt Ltd. Business Overview
11.9.3 Oscar Medicare Pvt Ltd. Neglected Tropical Disease Treatments Introduction
11.9.4 Oscar Medicare Pvt Ltd. Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.9.5 Oscar Medicare Pvt Ltd. Recent Development
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Detail
11.10.2 Thermo Fisher Scientific, Inc. Business Overview
11.10.3 Thermo Fisher Scientific, Inc. Neglected Tropical Disease Treatments Introduction
11.10.4 Thermo Fisher Scientific, Inc. Revenue in Neglected Tropical Disease Treatments Business (2019-2024)
11.10.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
